Myeloma BioBank
At the Institute for Myeloma & Bone Cancer Research (IMBCR)
Why Choose Myeloma BioBank?
We are uniquely focused on Myeloma and Plasma Cell Dyscrasias,
providing access to a world-class biorepository of
clinically characterized blood & bone marrow samples
Over 35,000 samples from 3,400 patients
Longitudinal samples frequently collected from patients
Samples from a single specialty practice for more than 20 years
The ability to obtain both retrospective & prospective samples
Comprehensive demographic and clinical data
Currently approved treatments as well as novel regimens
Sample Types Include
- Plasma and serum (frozen at -20°C)
- Bone marrow cells and biopsies (frozen at -70°C or in liquid nitrogen, or paraffin-embedded)
- Peripheral blood mononuclear cells (frozen at -70°C, in liquid nitrogen, or fixed in formaldehyde)
- Prospective collection capabilities available upon request for all sample types
BioBank Difference
“The samples we received from the biobank were well-organized, and it was easy to identify each sample. The labeling of the samples, boxes, and documentation was clearly marked, making the whole process smooth and efficient.
” Karen Anderson at Sebia"
Largest Single Resource
Samples are available from a single clinic specializing in the care of these patients.
Long-Term Follow-Up
Samples with accurate and informative clinical data can be adapted to your individualized research specific needs.
Multiple Samples per Patient
Frequently collected samples are available from over 35,000 samples from 3,400 patients who have received the most currently approved treatments as well as novel regimens.
Cost Effective
You can bypass unnecessary costs, delays, and complexities often encountered with academic and third-party groups unfamiliar with myeloma and related diseases.
Our Mission
Myeloma BioBank is dedicated to providing researchers with the highest quality blood and bone marrow samples for multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.
Our mission is to accelerate the discovery of new treatments and cures for these diseases through the rapid provision of high quality samples from patients with comprehensive and longitudinal clinical data.